Treatment-related adverse effects with pazopanib, sorafenib and sunitinib in patients with advanced soft tissue sarcoma: a pooled analysis

OBJECTIVE: Research efforts have investigated therapies targeting tyrosine kinase signaling pathways. We performed a pooled analysis to determine the frequency of severe adverse effects in patients with soft tissue sarcoma treated with pazopanib, sorafenib and sunitinib. MATERIALS AND METHODS: We pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Que, Yi, Liang, Yao, Zhao, Jingjing, Ding, Ya, Peng, Ruiqing, Guan, Yuanxiang, Zhang, Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055834/
https://www.ncbi.nlm.nih.gov/pubmed/30050324
http://dx.doi.org/10.2147/CMAR.S164535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055834/
https://www.ncbi.nlm.nih.gov/pubmed/30050324
http://dx.doi.org/10.2147/CMAR.S164535

Ejemplares similares